Exscientia Announced The Advancement Of Two Additional Discovery Programs Within Its Collaboration With Sanofi, With Exscientia Receiving An Aggregate Of $15M In Milestone Payments

Benzinga · 10/16 11:03

Both lead compounds have met the product profile requirements, set by both Exscientia and Sanofi, to enable a transition to the lead optimization phase within the collaboration. Both programs have also shown a high level of differentiation in early profiling and have the potential to produce best-in-class assets.